SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Novartis India reports 16% rise in Q2 net profit

31 Oct 2013 Evaluate

Novartis India has reported results for the second quarter ended September 30, 2013.

The company has reported a rise of 15.79% in its net profit of Rs 45.55 crore for the quarter as compared to Rs 39.34 crore for the same quarter in the previous year. However, total income from operation of the company has decreased by 9.90% at Rs 213.92 crore for quarter under review as compared to Rs 237.43 crore for the quarter ended September 30, 2012.

Novartis India is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare.

Novartis Share Price

1112.60 47.15 (4.43%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 222.80
Adani Enterprises 2505.65
Amrapali Industries 18.21
Rashi Peripheral 530.50
PDS 300.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×